130 related articles for article (PubMed ID: 30905445)
1. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
Tang Y; Cui Y; Zhang S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.
Zhang M; Dou H; Yang D; Shan M; Li X; Hao C; Zhang Y; Zeng P; He Y; Liu Y; Fu J; Wang W; Hu M; Li H; Tian Q; Lei S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():141-163. PubMed ID: 30905446
[TBL] [Abstract][Full Text] [Related]
3. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
4. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
5. Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future.
Hu M; Lan Y; Lu A; Ma X; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():1-24. PubMed ID: 30905444
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteins in the Sera of Oncological Patients.
Hernychová L; Uhrík L; Nenutil R; Novotný MV
Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
8. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract][Full Text] [Related]
9. Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies.
Silva ML
Biochim Biophys Acta; 2015 Dec; 1856(2):165-77. PubMed ID: 26232626
[TBL] [Abstract][Full Text] [Related]
10. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
[TBL] [Abstract][Full Text] [Related]
11. Developments in the identification of glycan biomarkers for the detection of cancer.
Ruhaak LR; Miyamoto S; Lebrilla CB
Mol Cell Proteomics; 2013 Apr; 12(4):846-55. PubMed ID: 23365456
[TBL] [Abstract][Full Text] [Related]
12. Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells.
Wang D; Wu L; Liu X
Adv Exp Med Biol; 2017; 994():275-284. PubMed ID: 28560680
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against aberrant glycans as cancer biomarkers.
Blsakova A; Kveton F; Kasak P; Tkac J
Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
[No Abstract] [Full Text] [Related]
14. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
15. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
[TBL] [Abstract][Full Text] [Related]
16. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
17. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
18. Serum CA153 as biomarker for cancer and noncancer diseases.
Li X; Xu Y; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
20. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
